Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "【Order On Telegram: @Chem2Door】Where To Buy Lunesta In San Diego,.7093"

Looking for quality documents?
external link icon
Repligen to Report Fourth Quarter and Full Year 2017 Financial Results
WALTHAM, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report fourth quarter and full year 2017 financial results on Thursday, February 22, 2018. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EST to discuss business updates and financial results for the three and twelve-month reporting periods ended December 31, 2017. The conference call will be accessible by dialing toll-free (866) 777-2509 for domestic callers and (412) 317-5413 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (877) 344-7529 for callers in the U.S., (855) 669-9658 for callers in Canada and (412) 317-0088 for international callers. Replay
external link icon
Repligen to Report Fourth Quarter and Full Year 2015 Financial Results
WALTHAM, Mass., Feb. 17, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report fourth quarter and full year 2015 financial results on Thursday, February 25, 2016. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the reporting period ended December 31, 2015. The conference call will be accessible by dialing toll-free (844) 835-7432 for domestic callers and (404) 537-3372 for international callers. Participants must provide the passcode 41151742. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Replay listeners must provide the passcode 41151742. About Repligen
external link icon
Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results
WALTHAM, Mass., Feb. 25, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report fourth quarter and fiscal year 2013 financial results on Thursday, March 6, 2014. The Company will issue a press release before the market opens and will host a conference call at 9:00 a.m. EST to discuss business updates and financial results for the reporting periods ended December 31, 2013. In addition, the Company will provide financial guidance for its fiscal year 2014. Repligen's fourth quarter conference call will be accessible by dialing (866) 318-8620 for domestic callers or (617) 399-5139 for international callers. Dial-in participants must provide the passcode 47036442. Alternatively, a webcast will be accessible via the Investor section of Repligen's website www.repligen.com . Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (888) 286-8010 for domestic callers and (617)
external link icon
Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference
WALTHAM, Mass., Nov. 26, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present an overview of the Company at the 25 th Annual Piper Jaffray Healthcare Conference on Tuesday, December 3 at 9:50 a.m. EST. The conference will be held December 3-4, 2013 at the New York Palace Hotel in New York. A live audio webcast of the Repligen presentation will be accessible through the Investor Relations section of Company's website at www.repligen.com ; see News & Events, Events & Presentations. This webcast will also be archived for a period of time on the Company's website. About Repligen Corporation Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies
external link icon
Repligen to Report Fourth Quarter and Full Year 2012 Financial Results
WALTHAM, Mass., March 1, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) announced today that it will report financial results for the fourth quarter and year ended December 31, 2012 on March 7. On this date, the Company will issue a press release prior to the opening of the NASDAQ Global Market, followed by a conference call and webcast at 9:00 a.m. EST to discuss financial results for the reporting period. The event will be hosted by Walter C. Herlihy, Ph.D., President and CEO of Repligen. Repligen's fourth quarter and year end conference call will be accessible by dialing (800) 291-5365 for domestic callers or (617) 614-3922 for international callers. Dial-in participants must provide the passcode 66969032 . Alternatively, an audio webcast will be accessible via the Investors section of Repligen's website www.repligen.com . Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (888) 286-8010
external link icon
Repligen Licenses Rights to Use of HDAC3 Inhibitors for Memory Disorders
external link icon
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
external link icon
Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
external link icon
Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
news icon
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support